BRASKEM SA-CLASS A- ADR

BAK stock represents a U.S.-listed American Depositary Receipt (ADR) tied to Braskem S.A., a Brazilian petrochemical company. Each ADR corresponds to an interest in the underlying shares traded on Brazil's B3 exchange. As an ADR, BAK allows U.S. investors to gain exposure to Braskem's equity without directly trading on foreign markets. For current details, refer to the BAK quote page.

Recent performance for BAK can be found under the price and performance section of this page. Short-term moves often reflect changes in petrochemical spreads, Brazilian real fluctuations, and broader market sentiment. Because these factors shift frequently, consult the live BAK quote for the latest price, percentage change, and trading volume rather than relying on dated figures.

The 52-week range shows the lowest and highest prices at which BAK traded over the past year. It helps gauge how volatile the stock has been and where the current price sits relative to that span. The exact low and high are displayed in the price data on this page and should be checked for the most current reading.

Valuation for BAK typically involves comparing metrics like price-to-earnings, price-to-sales, and enterprise value-to-EBITDA against petrochemical peers and the company's own history. Because BAK is tied to a Brazilian ADR, currency movements and regional economic conditions can also affect relative value. Review the valuation ratios shown on this page for the latest figures.

Braskem, the company behind BAK, has historically paid dividends, but payments can vary based on earnings, cash flow, and Brazilian corporate rules. ADR holders may receive distributions after applicable withholding taxes and fees. For current dividend information, check the dividend section on this page, as amounts and timing are not fixed.

Key risks include volatility in petrochemical prices, exposure to Brazilian political and economic conditions, currency fluctuations between the real and U.S. dollar, and dependence on global industrial demand. As an ADR, BAK also carries foreign regulatory and liquidity considerations. These factors can affect earnings, cash flow, and the stock's market value.